Factors of imatinib resistance in chronic myeloid leukemia

被引：0
|
作者：
Kajtar, B. [1 ]
Alpar, D. [1 ]
Toth, J. [1 ]
Laszlo, R. [1 ]
Jakso, R. [1 ]
Kereskai, L. [1 ]
Nagy, Z. [1 ]
Pajor, L. [1 ]
机构：
[1] Univ Pecs, Dept Pathol, H-7622 Pecs, Hungary
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
D O I：
10.1016/S0268-960X(07)70053-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [31] Overexpression of P-glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients
    Ammar, Mariam
    Louati, Nour
    Frikha, Imen
    Medhaffar, Moez
    Ghozzi, Hanen
    Elloumi, Moez
    Menif, Hela
    Zeghal, Khaled
    Ben Mahmoud, Lobna
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (09)
  • [32] ZFX Facilitates Cell Proliferation and Imatinib Resistance in Chronic Myeloid Leukemia Cells
    Jingjing Wu
    Bin Wei
    Qian Wang
    Yihan Ding
    Zhikui Deng
    Xueying Lu
    Yufeng Li
    Cell Biochemistry and Biophysics, 2016, 74 : 277 - 283
  • [33] Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
    Swords, Ronan
    Mahalingam, Devalingam
    Padmanabhan, Swaminathan
    Carew, Jennifer
    Giles, Francis
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2009, 3 : 89 - 101
  • [34] Nuclear hormone receptors modulate imatinib resistance in chronic myeloid leukemia (CML)
    Rajamani, Bharathi M.
    Karathedath, Sreeja
    Illangeswaran, Raveen Stephen
    Benjamin, Esther Sathya Bama
    Mathews, Vikram
    Abraham, Aby
    Balasubramanian, Poonkuzhali
    CANCER RESEARCH, 2018, 78 (13)
  • [35] Molecular genetic and epigenetic markers of Imatinib resistance in chronic myeloid leukemia patients
    Elias, Marjanu Hikmah
    Azlan, Husin
    Sulong, Sarina
    Hassan, Rosline
    Baba, Abdul Aziz
    Ankathil, Ravindran
    ANNALS OF ONCOLOGY, 2016, 27
  • [36] Dynamics of Chronic Myeloid Leukemia Under Imatinib Treatment: A Study of Resistance Development
    Badralexi, Irina
    Bordei, Ana-Maria
    Halanay, Andrei
    Radulescu, Ileana Rodica
    MATHEMATICS, 2024, 12 (24)
  • [37] hTERT Promotes Imatinib Resistance in Chronic Myeloid Leukemia Cells: Therapeutic Implications
    Deville, Laure
    Hillion, Josette
    Pendino, Frederic
    Samy, Mona
    Nguyen, Eric
    Segal-Bendirdjian, Evelyne
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (05) : 711 - 719
  • [38] ZFX Facilitates Cell Proliferation and Imatinib Resistance in Chronic Myeloid Leukemia Cells
    Wu, Jingjing
    Wei, Bin
    Wang, Qian
    Ding, Yihan
    Deng, Zhikui
    Lu, Xueying
    Li, Yufeng
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2016, 74 (02) : 277 - 283
  • [39] BCR- ABL KINASE MUTATIONS TO IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA
    Thungappa, S. Chiradoni
    Singh, T.
    Rashmi, N. R.
    Lokanatha, D.
    Rajshekar, H.
    Lakshmaiah, K. C.
    Babu, K. G.
    Suresh, T. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 357 - 357
  • [40] The roles of STAT transcription Factors in imatinib resistance and sensitivity in BCR/ABL positive chronic myeloid leukemia cells
    Baran, Y.
    Kosova, B.
    Tezcanli, B.
    Ekiz, H. A.
    Cakir, Z.
    Selvi, N.
    EJC SUPPLEMENTS, 2010, 8 (05): : 52 - 53
12345